158 related articles for article (PubMed ID: 19362489)
1. Monte Carlo and analytical calculations of dose distributions in craniopharyngioma cysts treated with radiocolloids containing 32P or 186Re.
Sadeghi M; Karimi E; Sardari D
Appl Radiat Isot; 2009 Sep; 67(9):1697-701. PubMed ID: 19362489
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison of 90Y, 32P, and 186Re radiocolloids in craniopharyngioma treatments.
Sadeghi M; Karimi E; Hosseini SH
Med Phys; 2009 Nov; 36(11):5022-6. PubMed ID: 19994512
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry of (32)P radiocolloid for treatment of cystic craniopharyngioma.
Sadeghi M; Moradi S; Shahzadi S; Pourbeigi H
Appl Radiat Isot; 2007 May; 65(5):519-23. PubMed ID: 17350270
[TBL] [Abstract][Full Text] [Related]
4. Dosimetry for radiocolloid therapy of cystic craniopharyngiomas.
Rojas EL; Al-Dweri FM; Lallena AM; Bodineau C; Galán P
Med Phys; 2003 Sep; 30(9):2482-92. PubMed ID: 14528970
[TBL] [Abstract][Full Text] [Related]
5. Management of cystic craniopharyngiomas with stereotactic endocavitary irradiation using colloidal 186Re: a retrospective study of 48 consecutive patients.
Derrey S; Blond S; Reyns N; Touzet G; Carpentier P; Gauthier H; Dhellemmes P
Neurosurgery; 2008 Dec; 63(6):1045-52; discussion 1052-3. PubMed ID: 19057317
[TBL] [Abstract][Full Text] [Related]
6. [Curative effect of stereotactic 186Re endocavitary irradiation on cystic craniopharyngioma].
Guo CJ; Wang YC; Zhou ZH; Zhu JX; Li ZM; Guo CL
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):548-50. PubMed ID: 21029702
[TBL] [Abstract][Full Text] [Related]
7. [Stereotaxic treatment of expanding cysts in craniopharyngiomas by endocavitary beta-irradiation (Re-186; Au-198; Y-90)].
Musolino A; Munari C; Blond S; Betti O; Lajat Y; Schaub C; Askienazy S; Chodkiewicz JP
Neurochirurgie; 1985; 31(3):169-78. PubMed ID: 3897891
[TBL] [Abstract][Full Text] [Related]
8. Intracavitary therapy of craniopharyngiomas.
Shapiro B; Fig LM; Gross MD
Q J Nucl Med; 1999 Dec; 43(4):367-74. PubMed ID: 10731787
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison of Y90, P32, and Re186 radiocolloids in craniopharyngioma treatments.
Sadeghi M; Karimi E; Hosseini SH
Med Phys; 2009 Nov; 36(11):5022-5026. PubMed ID: 28525091
[TBL] [Abstract][Full Text] [Related]
10. Dose distribution outside of a sphere of P-32 chromic phosphorous colloid.
Hechtman CD; Li Z; Mansur DB; Perez CA; Myerson RJ; Simpson JR; Anders JC; Wu C; Palucci CA
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):961-8. PubMed ID: 16199325
[TBL] [Abstract][Full Text] [Related]
11. Management of cystic craniopharyngiomas with intracavitary irradiation with 32P.
Shahzadi S; Sharifi G; Andalibi R; Zali A; Ali-Asgari A
Arch Iran Med; 2008 Jan; 11(1):30-4. PubMed ID: 18154420
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Bremsstrahlung radiation dose in stereotactically radiocolloid therapy of cystic craniopharyngioma tumors with
Babaei M; Ghahramani-Asl R; Sadoughi HR; Sardari D; Shahzadi S
Australas Phys Eng Sci Med; 2018 Sep; 41(3):697-711. PubMed ID: 29987510
[TBL] [Abstract][Full Text] [Related]
13. Phosphorus-32 therapy of cystic Grade IV astrocytomas: technique and preliminary application.
Taasan V; Shapiro B; Taren JA; Beierwaltes WH; McKeever P; Wahl RL; Carey JE; Petry N; Mallette S
J Nucl Med; 1985 Nov; 26(11):1335-8. PubMed ID: 2997419
[TBL] [Abstract][Full Text] [Related]
14. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy.
Prestwich WV; Nunes J; Kwok CS
J Nucl Med; 1989 Jun; 30(6):1036-46. PubMed ID: 2738686
[TBL] [Abstract][Full Text] [Related]
15. Internal irradiation for cystic craniopharyngioma.
Kobayashi T; Kageyama N; Ohara K
J Neurosurg; 1981 Dec; 55(6):896-903. PubMed ID: 6271932
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of the dose to the cyst wall in P-32 radiocolloid treatments of cystic brain tumors using the dose-point-kernel and Monte Carlo methods.
Janicki C; Seuntjens J
Med Phys; 2003 Sep; 30(9):2475-81. PubMed ID: 14528969
[TBL] [Abstract][Full Text] [Related]
17. A Monte Carlo simulation model for radiation dose to metastatic skeletal tumor from rhenium-186(Sn)-HEDP.
Samaratunga RC; Thomas SR; Hinnefeld JD; Von Kuster LC; Hyams DM; Moulton JS; Sperling MI; Maxon HR
J Nucl Med; 1995 Feb; 36(2):336-50. PubMed ID: 7830140
[TBL] [Abstract][Full Text] [Related]
18. Visual outcome in cystic craniopharyngiomas treated with intracavitary phosphorus-32.
Anderson DR; Trobe JD; Taren JA; Gebarski SS
Ophthalmology; 1989 Dec; 96(12):1786-92. PubMed ID: 2622622
[TBL] [Abstract][Full Text] [Related]
19. Phosphorus-32 therapy for cystic craniopharyngiomas.
Barriger RB; Chang A; Lo SS; Timmerman RD; DesRosiers C; Boaz JC; Fakiris AJ
Radiother Oncol; 2011 Feb; 98(2):207-12. PubMed ID: 21269713
[TBL] [Abstract][Full Text] [Related]
20. Patient-specific dosimetry for intracavitary 32P-chromic phosphate colloid therapy of cystic brain tumours.
Denis-Bacelar AM; Romanchikova M; Chittenden S; Saran FH; Mandeville H; Du Y; Flux GD
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1532-41. PubMed ID: 23740370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
